Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02387216
Title A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Merrimack Pharmaceuticals
Indications

lung non-small cell carcinoma

Therapies

Seribantumab

Pemetrexed Disodium

Docetaxel

Age Groups: adult
Covered Countries USA | FRA | ESP | DEU | CAN

Additional content available in CKB BOOST